[The design and baseline characteristics of a phase III study to evaluate the efficacy and safety of alogliptin versus placebo in type 2 diabetes mellitus in Mainland China].
Pan CY, Li WH, Zeng JE, Li CJ, Yang JK, Ji QH, Lu JM, Lü XF, Li XF, Qu S, Xu XJ, Xue YM, Li L, Jiang ZS, Zheng BZ, Bu RF, Han P, Liu Y, Liu JD, Peng YD, Liu XM, Liu ZM, Yan L, Lei MX, Li XJ, Song QH, Shi BY, Gu W, Li ZF.
Pan CY, et al. Among authors: lu xf, lu jm.
Zhonghua Nei Ke Za Zhi. 2013 Nov;52(11):932-5.
Zhonghua Nei Ke Za Zhi. 2013.
PMID: 24439186
Clinical Trial.
Chinese.